4//SEC Filing
Thompson Alexis A. 4
Accession 0000899243-21-024978
CIK 0001629137other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:23 PM ET
Size
13.3 KB
Accession
0000899243-21-024978
Insider Transaction Report
Form 4
Thompson Alexis A.
Director
Transactions
- Award
Restricted Stock Units
2021-06-17+908→ 908 total→ Common Stock (908 underlying) - Award
Stock Option (Right to Buy)
2021-06-17+1,412→ 1,412 totalExercise: $37.09Exp: 2031-06-16→ Common Stock (1,412 underlying)
Footnotes (3)
- [F1]The shares subject to this option shall vest and become exercisable in equal monthly installments over a period of 12 months following June 17, 2021 for 11 months and the remaining 1/12th on the earlier of (i) June 17, 2022 or (ii) the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Issuer's Board of Directors. This option is subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended).
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]The shares of Common Stock underlying the RSUs vest in a single installment on the earlier of (i) June 17, 2022 or (ii) the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Issuer's Board of Directors. The shares of Common Stock underlying the RSUs are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended).
Issuer
Global Blood Therapeutics, Inc.
CIK 0001629137
Entity typeother
Related Parties
1- filerCIK 0001851895
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:23 PM ET
- Size
- 13.3 KB